Intra-arterial Allogeneic Mesenchymal Stem Cells for Critical Limb Ischemia are Safe and Efficacious: Report of a Phase I Study

Angiographic Demonstration of Neoangiogenesis after Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Diabetic Patients with Critical Limb Ischemia

(2012) Rafael Ruiz-Salmeron et al.   CELL TRANSPLANTATION

A Phase II Trial of Autologous Transplantation of Bone Marrow Stem Cells for Critical Limb Ischemia: Results of the Naples and Pietra Ligure Evaluation of Stem Cells Study

(2012) Alessandro Schiavetta et al.   Stem Cells Translational Medicine

Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia

(2011) Dirk H. Walter et al.   Circulation-Cardiovascular Interventions

Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia

(2011) Michael P. Murphy et al.   JOURNAL OF VASCULAR SURGERY

Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia

(2011) Mark D. Iafrati et al.   JOURNAL OF VASCULAR SURGERY

Human endothelial stem/progenitor cells, angiogenic factors and vascular repair

(2010) S. M. Watt et al.   Journal of the Royal Society Interface